BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose.

Lucantoni F, Dussmann H, Llorente-Folch I, Prehn JHM
Oncotarget. 2018 May 25;9(40):26046-26063. doi: 10.18632/oncotarget.25433. eCollection 2018 May 25. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.